Glooko Brings In $35 Million
Enterprise IT startup Glooko announced it has secured $35 million in Series C financing. Seven investors participated in the round: Georgian Partners, Mayo Medical Ventures, Canaan Partners, Social Capital, Medtronic, Samsung Ventures, and Insulet Corporation.
Glooko offers a unique diabetes management solution for patients, health systems, and payer groups. Its products – the Glooko mobile apps, MeterSync Cable for iOS and Android, and the Glooko Population Tracker – enable people with diabetes to self-manage their condition and allows the clinicians who care for them to obtain remote access blood glucose readings and other related data, as well as to provide coaching and support between clinic visits. Glooko automatically extracts data for more than 90% of the world’s diabetes devices, exercise and biometric trackers and includes a massive food and medication database for tracking and care plan reminders.
The company revealed that Glooko will use the funds to accelerate growth by expanding its sales, marketing, and development teams.
